Replies to post #34198 on Lexaria Bioscience Corp (LEXX)

[Shawking]

I think it's very bullish that Juvenescence prefers to develop a Sulforathane product with LEXX and canceled an existing deal with Evgen, which cost them some money. They must have tried their Sulforathane product with DehydraTECH and saw much better bioavailability, which would be a great endorsement of the technology.
Thanks again to pieinthesky for leading us down this trail!